02.10.2014 Views

Programma finale completo - SIF - Università degli Studi di Torino

Programma finale completo - SIF - Università degli Studi di Torino

Programma finale completo - SIF - Università degli Studi di Torino

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

213. Estrogen receptor antagonist ICI 182,780 inhibits the anti-inflammatory effect of<br />

glucocorticoids<br />

1,2 Salvatore Cuzzocrea, 3 Bruscoli S., 1 Crisafulli C., 1,2 Mazzon E., 3 Agostini M., 1 Muià C.,<br />

2,4 Esposito E.,<br />

3 Di Virgilio R.,<br />

4 Meli R.,<br />

5 Vegeto E.,<br />

5 Maggi A.,<br />

3 Riccar<strong>di</strong> C.<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina,<br />

Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy; 3 Department of Cinical and<br />

Experimental Me<strong>di</strong>cine, Pharmacology, University of Perugia, Italy;<br />

4 Department of<br />

Experimental Pharmacology, University of Naples “Federico II”, Naples Italy; 5 Department of<br />

Pharmacological Sciences, University of Milan, Italy<br />

Chemioterapia antibatterica, antivirale e antineoplastica<br />

Poster 214 – 228<br />

214. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and ZD6474 in<br />

bladder cancer cell lines<br />

Mey Valentina, Elisa G., Nannizzi S., Ricciar<strong>di</strong> S., Danesi R., Del Tacca M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine,<br />

University of Pisa<br />

215. Synergistic cytotoxycity, inhibition of AKT and C-KIT phosphorylation, modulation of<br />

gene expression by sorafenib and gemcitabine in human pancreatic cancer cells<br />

Ricciar<strong>di</strong> Simona, Giovannetti E. , Nannizzi S., Mey V., Pasqualetti G., Danesi R., Del Tacca<br />

M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa<br />

216. Inhibition of STAT 3 increases doxorubicin sensitivity in a human metastatic breast<br />

cancer cell line<br />

Roberta Molteni, Ravizza R., Garibol<strong>di</strong> M.B., Monti E.<br />

Dept. of Structural and Functional Biology, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> dell’Insubria<br />

103<br />

217. In vitro study of the interaction between gemcitabine and sorafeniv in non small<br />

cell lung cancer (NSCLC) A549 cell line<br />

Pasqualetti Giuseppe, Ricciar<strong>di</strong> S., Nannizzi S., Mey V., Elisa G., Danesi R., Del Tacca M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine - University of<br />

Pisa<br />

218. In vitro and in vivo antineoplastic effects of a novel platinum bioconjugate using a<br />

biocompatible polymeric matrix<br />

Garibol<strong>di</strong> Marzia Bruna, Gabano E. 1 , Sparnacci K. 1 , Laus M. 1 , Osella D. 1 , Ravizza R., Molteni<br />

R., Monti E.<br />

DBSF – Pharmacology Section, University of Insubria, Busto Arsizio (VA). 1 Dipartimento <strong>di</strong><br />

Scienze dell’Ambiente e della Vita, Università del Piemonte Orientale “A. Avogadro”,<br />

Alessandria<br />

219. Toxicological evaluation of mepacrine and interferon alfa-2A on U87-MG and Vero<br />

cell colture<br />

Coppi Andrea, Baggio G., Bruni E. Rossi T.<br />

University of Modena and Reggio Emilia- Italy: Departmentof Biome<strong>di</strong>cal Sciences-<br />

Section of Pharmacology; 287 G. Campi st 41100 Modena Italy<br />

pag_dx.indd 1 30/05/2007 4.39.14

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!